10-K/A

FORM 10-K AMENDMENT

Company: PharmaCyte Biotech, Inc.
Filed: October 17, 2014
Period of Report: April 30, 2014
Accession Number: 0001019687-14-003893

View Document ↗ View on SEC.gov ↗